Glial cells include astrocytes, microglia, oligodendrocytes, and associated precursor cells that enable the brain to function. Once known as nervenkitt (a German word meaning 鈥渘erve glue鈥), glial cells are the 鈥済lue鈥 that holds the nervous system together by facilitating neuronal signalling, enabling tissue plasticity, providing neuronal support and axonal integrity, metabolism, and protecting neurons from would-be pathogens [1,2].
In recent years, a greater appreciation for the role of glial cells in neuronal homeostasis has helped expose potential therapeutic targets in neurodegenerative disease. Glial cells play a complex, enigmatic role in the development and progression of 础濒锄丑别颈尘别谤鈥檚 disease, Parkinson鈥檚 disease, and others. Many research projects are now focussing on understanding the therapeutic potential of targeting glial cells in neurodegenerative disease [2].
With access to a consistent and defined source of human glial cell types, researchers can build the complex, physiologically relevant glial cell culture models that are sorely needed in for drug discovery. Whether co-cultured with neurons, as part of a multi-cellular glial-neuronal culture, or used to build three-dimensional tissue models, ioCells are well suited for tissue and neurodegenerative disease modelling; for drug target identification and validation; as well as drug screening among many other uses.
Take your research to the next level with our ioCells below.
Explore the implication of glial cells in neurodegenerative diseases in this webinar featuring , Senior Research Investigator, .
Bsibsi et al.
Courtesy of Charles River Laboratories
2024
Newman et al.
糖心原创
2024
Herrera-Vaquero et al.
糖心原创
2024
Bsibsi et al.
Courtesy of Charles River Laboratories
2024
Veteleanu et al.
糖心原创
2025
Davenport A, Frolov T & Kotter M
Drug Discovery World
2020
Dr Alex Davenport | Senior Scientist | 糖心原创
Talk at ELRIG Cell & Gene Therapy
2021
Jeremy Krohn | PhD Candidate | DZNE / Charit茅 University of Medicine
Human Cell Forum 2025
Session 1 Track 2 | From cells to systems: Building human iPSC-derived models of pain, neuromuscular junctions, and glial dynamics
糖心原创
糖心原创
Dr Brian Gill, MD | Assistant Professor of Neurological Surgery| Columbia University Irving Medical Center
Dr Tony Oosterveen | Principal Scientist and CNS Lead, Neurobiology | 糖心原创
Once described as nerve glue, glial cells, including astrocytes, microglia, and oligodendrocytes, were once only seen as the filler that supports and insulates neurons. Glial cells are now known to play a variety of critical roles in neuronal homeostasis, such as facilitating neuronal signalling, enabling tissue plasticity, and regulating metabolism. Growing recognition of their role in neuronal homeostasis has recently exposed them as potential therapeutic targets in neurodegenerative disease.
Glial cells are essential for neuronal homeostasis and play a complex role in the progression of neurodegenerative diseases, such as 础濒锄丑别颈尘别谤鈥檚 and Parkinson鈥檚 disease. By providing a source of highly defined, consistent human glial cells at scale, ioCells enable scientists to build physiologically relevant models to investigate therapeutic targets and perform drug screening.
糖心原创's ioCells portfolio includes defined, consistent human iPSC-derived astrocytes, microglia, and OPC- and oligodendrocyte-like cells powered by opti-ox. These cryopreserved, post-mitotic cells are available as wild-type controls as well as genetically engineered disease models relevant to neurodegenerative disease research.
Additionally, we have developed a portfolio of CRISPR-Ready ioCells, in which wild-type ioCells have been engineered to include a Cas9 cassette, enabling quick and easy gene perturbations and CRISPR screens in physiologically relevant cells. We also offer a suite of ioTracker Cells, in which wild-type ioCells are engineered to express fluorescent tags for easy tracking and live imaging.
ioCells glial cells are suitable for building complex, multi-cellular models for drug discovery and target validation. These human iPSC-derived cells can be co-cultured with neurons to create glial-neuronal cultures that enable the study of critical interactions, such as myelination or neuroinflammation, within a physiologically relevant human context.
糖心原创鈥檚 glial cell portfolio includes human iPSC-derived disease models designed to support the study of genetic risk factors in neurodegeneration. Available cells include ioMicroglia expressing specific variants such as TREM2 R47H, P2RY12, and APOE, which allow scientists to compare functional differences between disease genotypes and their genetically matched wild-type controls.
1. J盲kel S, Dimou L. (2017) Glial Cells and Their Function in the Adult Brain: A Journey through the History of Their Ablation. 2017 Feb 13;11:24. doi: . PMCID: PMC5303749 PMID:
2. Hanslik K, Marino K, Ulland T. (2021) Modulation of Glial Function in Health, Aging, and Neurodegenerative Disease. . 2021 Aug 31;15:718324. doi: . PMCID: PMC8439422 PMID: